iShares Global Healthcare ETF (IXJ) Review & Analysis

MER Β· Top 50%AUM Β· Top 25%1Y Return Β· Top 25%3Y Return Β· #217 of 3005Y Return Β· #114 of 225
What's new this monthData to 30 September 2026
  • +2.0% in September (total return), ahead of the median international shares ETF at +0.0%.
  • Investors added a net $11m (0.7% of the fund).
  • The unit price closed the month at $147.08, 4% below its 12-month high (range $124.74 to $153.20).

About IXJ

IXJ is the iShares Global Healthcare ETF. It tracks the S&P Global 1200 Health Care Sector Index, holding around a hundred of the world's largest health care companies, including drug makers, medical device companies and health insurers. It is passive and unhedged.

The fund is led by large US and European groups such as Eli Lilly, Johnson & Johnson, AbbVie, Merck, Roche and Novartis, and most of the money is in the US. Health care tends to be more defensive than the broad market, as people need medicines and treatment in good times and bad, though individual companies face risks from drug trials, patent expiries and government pricing pressure. Income is modest and unfranked. Being unhedged, returns move with the US dollar.

IXJ is often used as a sector satellite, either to add a defensive tilt or to back long term trends such as ageing populations. Alternatives include DRUG and broad global funds such as VGS. See IXJ vs DRUG and VGS vs IXJ.

IXJ distributions and dividend dates

IXJ pays distributions half-yearly, usually going ex-distribution in July and December, with payment about 11 days after the ex-date.

The latest distribution was $1.5397 per unit (0% franked), ex-distribution on 1 July 2026 and paid on 13 July 2026. To receive it you need to own IXJ before the ex-date.

Its distribution yield over the past 12 months is about 1.4%. Distributions vary and past payments are not a guide to future ones.

From ASX announcements, updated nightly. See every ETF in the dividend calendar.

Compare IXJ with

IXJ price by TradingView

Stock CodeIXJ
Fund ManageriShares
Asset ClassInternational shares
AUM$1.5bn
MER (%)0.41%
Net flows (Sep)+$11m
Last Price$147.08
52-Week Range$124.74 – $153.20
Bid/Ask Spread0.04%
Listing Date11/03/2009
ExchangeASX
Index trackedS&P Global 1200 Healthcare Sector Index
Issuer websiteiShares β†—

Performance (% return)

0%11%22%33%1M2.0%1Y14.9%3Y19.8%5Y33.1%
1 month+2.0%
1 year+14.9%
3 years p.a.+6.2%
5 years p.a.+5.9%

$10,000 invested…

1 year ago$11,4893 years ago$11,9785 years ago$13,308

Value at 30 September 2026 with distributions reinvested, before tax and brokerage.

Total returns including distributions, to 30 September 2026. 1M, 1Y, 3Y and 5Y bars are cumulative.

IXJ at a glance: strengths and things to watch

πŸ‘ Strengths

  • Large and established. $1.5bn under management, number 56 of 508 ETFs in Australia by size.
  • Cheap to trade. A bid/ask spread of 0.04%, so buying and selling costs little extra.
  • Long track record. Listed since 2009, through several market cycles.
  • In an uptrend. Its price has been trending up since 1 October (as at 14 November).

⚠️ Things to watch

  • Behind its peers. +5.9% a year over 5 years, against +8.8% for the median international shares ETF.

Worked out from IXJ's fees, size, flows, returns and trend against the 257 international shares ETFs in Australia, to 30 September 2026. General information, not a recommendation.

Joshua StegaetfadviserTrend check
Uptrend since 1 Oct 2026

IXJ is in an uptrend. Here's why that matters.

IXJ's price is above its 20-day average and its 10, 20, 50 and 200-day averages are stacked upward. The trend is on investors' side. Its price is at or near its 12-month high.

Why it matters: Uptrends are when satellite ETFs tend to do their best work. The key is knowing when the trend breaks, so gains aren't handed back.

At ETF Adviser the core of a portfolio stays invested through every stage, and satellite ETFs are only bought in an uptrend. Members get a weekly update on which ETFs are breaking out of a base and which trends have broken.

Nov 25Feb 26May 26Aug 26Nov 26
UptrendBaseDowntrend

IXJ weekly price, past 12 months, shaded by trend stage. Stage as at 14 November 2026, updated weekly. A technical label, not a recommendation.

IXJ vs its benchmark

How IXJ has done against the S&P Global 1200 Health Care Capped Index (net, AUD), after fees. For an index fund, a small shortfall roughly the size of the fee is normal.

IXJBenchmarkDifference
1 year+11.18%+11.86%-0.68%
3 years p.a.+6.08%+6.27%-0.19%
5 years p.a.+6.09%+6.26%-0.17%

Issuer figures to 30 September 2026, fund returns after fees. Source: iShares. Compare more ETFs vs their benchmark β†’

Investment Focus

Exposure Regions

Global

Themes & Sectors

Healthcare

Portfolio Breakdown

Top 10 holdings (48.2% of the fund)

SymbolCompany% assets
LLY11.62%
JNJ6.75%
ABBV5.34%
MRK4.15%
UNH4.12%
ROP3.88%
NOVN3.35%
AZN3.27%
TMO2.90%
AMGN2.84%

Sector breakdown

  • Health Care100.0%

Country breakdown

  • United States73.2%
  • Switzerland9.8%
  • United Kingdom5.0%
  • Japan3.6%
  • DK2.0%
  • France2.0%
  • Germany1.6%
  • BE1.1%
  • Other1.7%

Holdings from the issuer's published portfolio as at 30 October 2026. Breakdowns are based on the largest 115 positions, covering 100% of the fund. Compare IXJ's holdings with other ETFs β†’

Best-endeavours estimate. Built from each issuer's published holdings, which may be weeks or months old, may cover only part of a fund (some publish only their top 10) and are matched by company name. Figures may be incomplete or inaccurate. Check the issuer's website and PDS before relying on them. General information only.

Similar ETFs

CodeNameSame holdingsMERAUM1Y3Y p.a.5Y p.a.
DRUGBetashares Global Healthcare Currency Hedged ETF Currency hedged
73%
0.57%$173m+21.1%+7.3%+4.9%
HLTHVanEck Global Healthcare Leaders ETF
20%
0.45%$59m+5.5%+6.3%βˆ’0.1%
VGSVanguard MSCI Index International Shares ETF
9%
0.18%$18.7bn+10.1%+17.9%+11.8%
IVViShares S&P 500 ETF
10%
0.04%$14.9bn+10.1%+19.2%+13.4%
NDQBetashares Nasdaq 100 ETF
5%
0.48%$9.5bn+16.6%+23.8%+15.3%
QUALVanEck MSCI International Quality ETF
15%
0.40%$9.2bn+10.1%+16.1%+11.4%

Same holdings is the share of IXJ's money in companies the other ETF also holds, weighted by size. Most similar first, then ETFs in the same category. See every ETF like IXJ β†’

IXJ vs its closest alternatives

What actually differs between IXJ and the ETFs most like it. Data to 30 Sep 2026.

DRUG Betashares Global Healthcare Currency Hedged ETF

  • They share 73% of their holdings: a lot of doubling up.
  • IXJ is cheaper (0.41% vs 0.57%), worth about $10,607 on $100,000 over 20 years.
  • Over 3 years, a year: IXJ +6.2%, DRUG +7.3% (DRUG ahead by 1.1 percentage points).
  • IXJ is about 9 times larger ($1.5bn vs $173m), which usually means tighter trading spreads.
  • Different structure: IXJ is a standard fund, DRUG is currency hedged.

Full IXJ vs DRUG comparison β†’

HLTH VanEck Global Healthcare Leaders ETF

  • They share 20% of their holdings: some overlap.
  • IXJ is cheaper (0.41% vs 0.45%), worth about $2,680 on $100,000 over 20 years.
  • Over 3 years, a year: IXJ +6.2%, HLTH +6.3% (almost identical).
  • IXJ is much larger ($1.5bn vs $59m), which usually means tighter trading spreads.

Compare IXJ and HLTH side by side β†’

VGS Vanguard MSCI Index International Shares ETF

  • They share 9% of their holdings: mostly different companies.
  • VGS is cheaper (0.18% vs 0.41%), worth about $15,787 on $100,000 over 20 years.
  • Over 3 years, a year: IXJ +6.2%, VGS +17.9% (VGS ahead by 11.7 percentage points).
  • VGS is much larger ($18.7bn vs $1.5bn), which usually means tighter trading spreads.

Full IXJ vs VGS comparison β†’

General information only. Past performance is not a reliable indicator of future performance.

Popular comparisons

IXJ vs DRUGVGS vs IXJ

Related Reads

IXJ FAQs

What is the fee for IXJ?

IXJ charges a management fee (MER) of 0.41% a year, according to the TMX Australia monthly funds report as at 30 September 2026.

How big is IXJ?

IXJ had $1.5bn in funds under management as at 30 September 2026.

How has IXJ performed?

IXJ returned +14.9% over the year to 30 September 2026 (total return, including distributions). Over three years it returned +6.2% a year. Past performance is not a reliable indicator of future performance.

Who manages IXJ?

IXJ is managed by iShares and has been listed since March 2009.

Does IXJ pay monthly?

IXJ pays distributions twice a year, usually going ex-distribution in July and December. It does not pay monthly. If you want monthly income, see the ETF dividend calendar on ReviewETF for funds that pay every month.

When is the next IXJ distribution?

Based on its usual schedule, IXJ's next distribution should go ex around the start of December (around day 29), with payment about 11 days later. Dates can move, so check iShares' announcements to confirm.

What is IXJ's dividend yield?

IXJ's distribution yield over the past 12 months was about 1.6%. Yields change with the unit price and each payment, and are not a forecast.

What does IXJ hold?

IXJ's largest holdings are Eli Lilly & Co (11.6%), Johnson & Johnson (6.8%), AbbVie Inc (5.3%), Merck & Co Inc (4.2%), UnitedHealth Group Inc (4.1%). It holds about 115 investments in total. The biggest sector is health care at 100%. Holdings as at 30 October 2026.

Is IXJ currency hedged?

No, IXJ is unhedged. Its returns move with the Australian dollar: a falling dollar adds to returns and a rising dollar reduces them.

Disclaimer

This review is general information only and does not take into account your objectives, financial situation or needs. Consider the iShares product disclosure statement (PDS) and target market determination (TMD) before investing. Past performance is not a reliable indicator of future performance.